atrasentan has been researched along with thiazoles in 2 studies
Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (thiazoles) | Trials (thiazoles) | Recent Studies (post-2010) (thiazoles) |
---|---|---|---|---|---|
358 | 41 | 108 | 33,179 | 2,100 | 12,330 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kantoff, PW; Kennedy, A; Majeed, N; Padley, RJ; Pollak, M; Tolcher, AW | 1 |
Corn, PG; Dayyani, F; Gallick, GE; Logothetis, CJ | 1 |
1 review(s) available for atrasentan and thiazoles
Article | Year |
---|---|
Novel therapies for metastatic castrate-resistant prostate cancer.
Topics: Androstenes; Androstenols; Angiogenesis Inhibitors; Anilides; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Atrasentan; Benzamides; Bevacizumab; Biomarkers, Tumor; Bone Remodeling; Cancer Vaccines; Clinical Trials as Topic; Clusterin; Dasatinib; Denosumab; Endothelin-1; Humans; Immunotherapy; Indoles; Ipilimumab; Male; Mice; Mice, SCID; Molecular Targeted Therapy; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostate-Specific Antigen; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrroles; Pyrrolidines; RANK Ligand; Receptor Cross-Talk; Receptors, Androgen; Signal Transduction; Sunitinib; Taxoids; Thiazoles; Tissue Extracts; Treatment Failure; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2011 |
1 other study(ies) available for atrasentan and thiazoles
Article | Year |
---|---|
Other novel agents: Rationale and current status as chemopreventive agents.
Topics: Anticarcinogenic Agents; Atrasentan; Chromans; Humans; Male; Prostatic Neoplasms; Pyrrolidines; Receptors, Endothelin; Somatomedins; Thiazoles; Thiazolidinediones; Troglitazone; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors | 2001 |